LL
Insider
Louis G Lange
DirectorLouis G Lange (Director) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in NewAmsterdam Pharma Company N.V. (NAMS). The largest single filing was $1.3M of NAMS (44,173 sh × $30.41, as filed), executed Mar 11.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
2
0 buys · 2 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$2.2M
shares × price, as filed
Last traded
Mar 11
Filed Mar 12
Median ADV $32.2M across their filed names
Open performance→Volume by month
Buys $0
Sells $2.2M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
2 filings
Sector per market data · by filing · past 12 months
Most traded names
NAMSRecent filings
NAMSSALE
NewAmsterdam Pharma Company N.V.
View filing →
$1.3M44,173 sh × $30.41
Exec Mar 11
Filed Mar 12 · 5:30 PM ET NAMSSALE NewAmsterdam Pharma Company N.V. View filing → $829K
28,186 sh × $29.41
Exec Mar 6
Filed Mar 10 · 5:30 PM ET